1. Home
  2. SNCR vs VERU Comparison

SNCR vs VERU Comparison

Compare SNCR & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNCR
  • VERU
  • Stock Information
  • Founded
  • SNCR 2000
  • VERU 1971
  • Country
  • SNCR United States
  • VERU United States
  • Employees
  • SNCR N/A
  • VERU N/A
  • Industry
  • SNCR EDP Services
  • VERU Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNCR Technology
  • VERU Health Care
  • Exchange
  • SNCR Nasdaq
  • VERU Nasdaq
  • Market Cap
  • SNCR 87.5M
  • VERU 85.5M
  • IPO Year
  • SNCR 2006
  • VERU 1990
  • Fundamental
  • Price
  • SNCR $7.52
  • VERU $0.60
  • Analyst Decision
  • SNCR Strong Buy
  • VERU Strong Buy
  • Analyst Count
  • SNCR 1
  • VERU 2
  • Target Price
  • SNCR $13.00
  • VERU $4.00
  • AVG Volume (30 Days)
  • SNCR 144.1K
  • VERU 2.4M
  • Earning Date
  • SNCR 08-05-2025
  • VERU 08-07-2025
  • Dividend Yield
  • SNCR N/A
  • VERU N/A
  • EPS Growth
  • SNCR N/A
  • VERU N/A
  • EPS
  • SNCR N/A
  • VERU N/A
  • Revenue
  • SNCR $172,842,000.00
  • VERU $16,886,419.00
  • Revenue This Year
  • SNCR $2.07
  • VERU N/A
  • Revenue Next Year
  • SNCR $5.42
  • VERU N/A
  • P/E Ratio
  • SNCR N/A
  • VERU N/A
  • Revenue Growth
  • SNCR 4.64
  • VERU 134.43
  • 52 Week Low
  • SNCR $6.00
  • VERU $0.45
  • 52 Week High
  • SNCR $15.46
  • VERU $1.42
  • Technical
  • Relative Strength Index (RSI)
  • SNCR 54.62
  • VERU 51.85
  • Support Level
  • SNCR $7.10
  • VERU $0.54
  • Resistance Level
  • SNCR $7.98
  • VERU $0.60
  • Average True Range (ATR)
  • SNCR 0.44
  • VERU 0.04
  • MACD
  • SNCR 0.14
  • VERU -0.00
  • Stochastic Oscillator
  • SNCR 76.53
  • VERU 33.95

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Share on Social Networks: